Monika Anna Olszewska
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (22)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Gaultheria procumbens L. is a medicinal plant whose aerial parts (leaves, stems, and fruits) and methyl salicylate-rich essential oil (wintergreen oil) are used in phytotherapy to treat inflammation, muscular pain, and infection-related disorders. This overview summarises the current knowledge about ethnobotany, phytochemistry, pharmacology, molecular mechanisms, biocompatibility, and traditional use of G. procumbens and the wintergreen oil distilled from different plant organs. Over 70 hydrophilic compounds, including methyl salicylate glycosides, flavonoids, procyanidins, free catechins, caffeoylquinic acids, and simple phenolic acids, have been identified in G. procumbens plant parts. Moreover, aliphatic compounds, triterpene acids, and sterols have been revealed in lipophilic fractions. Furthermore, over 130 volatile compounds have been detected in wintergreen oil with dominating methyl salicylate (96.9–100%). The accumulated research indicates that mainly hydrophilic non-volatiles are responsible for the pharmacological effects of G. procumbens, primarily its potent anti-inflammatory, antioxidant, and photoprotective activity, with mechanisms verified in vitro and ex vivo in cellular and cell-free assays. The biological effectiveness of the dominant methyl salicylate glycoside—gaultherin—has also been confirmed in animals. Wintergreen oil is reported as a potent anti-inflammatory agent exhibiting moderate antioxidant and antimicrobial activity in vitro and significant insecticidal and larvicidal capacity. Together, G. procumbens accumulate a diverse fraction of polyphenols, triterpenes, and volatiles with validated in vitro and ex vivo biological activity but with the absence of in vivo studies, especially clinical trials concerning effective dose determination and toxicological verification and technological research, including drug formulation.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (19)
Joanna Kolodziejczyk-Czepas
University of Łódź, Faculty of Biology and Environmental Protection
Adrian Gajewski
assistant professor
Medical University of Lodz
Agnieszka Wosiak
Medical University of Lodz
Magdalena Rutkowska
Medical University of Lodz
Anna Magiera
Medical University of Lodz
Dagmara Wróbel-Biedrawa
Jagiellonian University Medical College
Monika Czerwińska
associated professor
Medical University of Warsaw
Katarzyna Hnatuszko-Konka
assistant professor
University of Łódź
Grażyna Budryn
Lodz University of Technology
Damian Kołat
Medical University of Lodz
Halina Zbikowska
associate professor/Ph.D.
University of Lodz, Faculty of Biology and Environmental Protection
Ewa Skała
University Professor
Medical University of Lodz
Ewa Balcerczak
Medical University of Lodz
Agnieszka Kicel
Assistant Professor
Medical University of Lodz
Izabela Grzegorczyk-Karolak
assistant professor
Medical University of Lodz
Anna Kiss
Medical University of Warsaw
Karolina Rudnicka
senior researcher, lecturer
University of Łódź
Piotr Michel
Medical University of Lodz
Agnieszka Krupa
assistant professor
University of Łódź
Make your next move.
Prepare your application
Review drafts before you send them.